ALGS vs KO · rev $3.6M vs P/E 25, rev $47.94B
Aligos Therapeutics Inc (ALGS) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
ALGS currently screens at market cap $44.1M. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the ALGS and KO stock pages for the full models.
Not investment advice.